ArticleCureus2024
Trigeminal Nerve Schwannoma: A Rare Case of Multisymptomatic Cranial Nerve Involvement.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schwannomas (SCs) are benign tumors composed of neoplastic Schwann cells and are relatively uncommon intracranially. Although these tumors are frequently associated with neurofibromatosis type 2 (NF2), they may also arise idiopathically, and their pathogenesis remains poorly understood. A 70-year-old Caucasian man presented with a two-month history of vertigo, gait imbalance, and decreased visual acuity in the left eye accompanied by photophobia, nausea, vomiting, and occasional headaches. On physical examination, he exhibited hyposmia, horizontal nystagmus, superior oblique palsy, decreased photoreactivity of the left pupil, hypoesthesia in the middle and lower left facial regions, and a positive Romberg sign. Non-contrast computed tomography (CT) revealed a hypodense, expansive lesion in the left mesencephalic-pontine region. Based on the radiological characteristics, the radiologist suggested ischemic injury or neoplasm as the leading diagnostic hypothesis. Magnetic resonance imaging (MRI) with contrast revealed a cystic-necrotic lesion with multiloculated characteristics in the left mesencephalic-pontine area, with significant mass effect and compression of the brainstem and adjacent ventricular pathway. The lesion was suspected to be a schwannoma, and the patient underwent surgical resection via left temporal and suboccipital craniotomy. Histopathological examination confirmed a schwannoma of the left trigeminal nerve. SCs are most commonly diagnosed in the second and third decades of life, often growing slowly and remaining asymptomatic until they reach a size sufficient to cause functional impairment. MRI is the imaging modality of choice, but histologic confirmation remains the gold standard for diagnosis. This case underscores the rarity of trigeminal nerve SCs presenting with symptoms resulting not only from the affected nerve but also from compression of adjacent structures, such as the vestibulocochlear and abducens nerves. It also highlights the importance of maintaining a high index of suspicion when diagnosing rare intracranial SCs. Advanced imaging techniques and comprehensive clinical evaluation are crucial for identifying complex neurological conditions, particularly when initial findings, such as CT results, suggest alternative diagnoses like stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.